These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 31745330)

  • 41. Antimicrobial drug discovery: lessons of history and future strategies.
    Travis A; Chernova O; Chernov V; Aminov R
    Expert Opin Drug Discov; 2018 Nov; 13(11):983-985. PubMed ID: 30136874
    [No Abstract]   [Full Text] [Related]  

  • 42. The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development.
    Takebe T; Imai R; Ono S
    Clin Transl Sci; 2018 Nov; 11(6):597-606. PubMed ID: 29940695
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug development: Time for teamwork.
    May M
    Nature; 2014 May; 509(7498):S4-5. PubMed ID: 24784427
    [No Abstract]   [Full Text] [Related]  

  • 44. Antibiotic development pipeline slows to a trickle.
    Burki T
    Lancet Infect Dis; 2017 Nov; 17(11):1128-1129. PubMed ID: 29115268
    [No Abstract]   [Full Text] [Related]  

  • 45. Economic Incentives for Antibacterial Drug Development: Literature Review and Considerations From the Transatlantic Task Force on Antimicrobial Resistance.
    Sciarretta K; Røttingen JA; Opalska A; Van Hengel AJ; Larsen J
    Clin Infect Dis; 2016 Dec; 63(11):1470-1474. PubMed ID: 27578820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. When Humans Met Superbugs: Strategies to Tackle Bacterial Resistances to Antibiotics.
    Bravo A; Ruiz-Cruz S; Alkorta I; Espinosa M
    Biomol Concepts; 2018 Dec; 9(1):216-226. PubMed ID: 30811343
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The 2012 Garrod lecture: discovery of antibacterial drugs in the 21st century.
    Chopra I
    J Antimicrob Chemother; 2013 Mar; 68(3):496-505. PubMed ID: 23134656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Challenges in Antibiotic R&D Calling for a Global Strategy Considering Both Short- and Long-Term Solutions.
    Kållberg C; Salvesen Blix H; Laxminarayan R
    ACS Infect Dis; 2019 Aug; 5(8):1265-1268. PubMed ID: 31144803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The antibiotic R&D pipeline: an update.
    Jabes D
    Curr Opin Microbiol; 2011 Oct; 14(5):564-9. PubMed ID: 21873107
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reinventing the antimicrobial pipeline in response to the global crisis of antimicrobial-resistant infections.
    Singer AC; Kirchhelle C; Roberts AP
    F1000Res; 2019; 8():238. PubMed ID: 30906539
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Steps to address anti-microbial drug resistance in today's drug discovery.
    Parish T
    Expert Opin Drug Discov; 2019 Feb; 14(2):91-94. PubMed ID: 30466326
    [No Abstract]   [Full Text] [Related]  

  • 52. Antibiotic drug discovery.
    Wohlleben W; Mast Y; Stegmann E; Ziemert N
    Microb Biotechnol; 2016 Sep; 9(5):541-8. PubMed ID: 27470984
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020.
    Infectious Diseases Society of America
    Clin Infect Dis; 2010 Apr; 50(8):1081-3. PubMed ID: 20214473
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current Technology in the Discovery and Development of Novel Antibacterials.
    Chung PY
    Curr Drug Targets; 2018; 19(7):832-840. PubMed ID: 28891454
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Economic Conundrum for Antibacterial Drugs.
    Shlaes DM
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31658969
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pull Incentives for Antibacterial Drug Development: An Analysis by the Transatlantic Task Force on Antimicrobial Resistance.
    Årdal C; Røttingen JA; Opalska A; Van Hengel AJ; Larsen J
    Clin Infect Dis; 2017 Oct; 65(8):1378-1382. PubMed ID: 29017240
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery and Development of New Anti-infectives: Perspectives and Prospective.
    Kothari V
    Curr Drug Discov Technol; 2020; 17(4):414. PubMed ID: 32907529
    [No Abstract]   [Full Text] [Related]  

  • 58. Bacterial histidine kinases as novel antibacterial drug targets.
    Bem AE; Velikova N; Pellicer MT; Baarlen Pv; Marina A; Wells JM
    ACS Chem Biol; 2015 Jan; 10(1):213-24. PubMed ID: 25436989
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Responsible use of negative research outcomes-accelerating the discovery and development of new antibiotics.
    Yu H
    J Antibiot (Tokyo); 2021 Sep; 74(9):543-546. PubMed ID: 34272495
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improving antibiotic markets for long-term sustainability.
    Kesselheim AS; Outterson K
    Yale J Health Policy Law Ethics; 2011; 11(1):101-67. PubMed ID: 21381513
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.